The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
October 1st 2024
Ustekinumab is a human monoclonal antibody targeting the cytokines interleukin (IL)-12 and IL-23, which play a rule in the inflammatory and immune responses.
Preprint Research on Pfizer COVID-19 Vaccine Shows Greater Efficacy Two Weeks Post Administration
February 1st 2021New data from an unreviewed, preprint research article indicate first-dose immunization efficacy of the Pfizer-BioNTech coronavirus 2019 vaccine improves by 51% 13-24 days post administration.
Read More
Efficacy and Safety of FOLFIRI for Previously Treated Advanced Pancreatic Cancer
January 29th 2021The treatment of 5-fluorouracil with levofolinate and irinotecan was found to be well-tolerated and effective as a second-line treatment for patients with gemcitabine-refractory advanced pancreatic cancer.
Read More
Walgreens Provides an Update on COVID-19 Vaccination Administration Across the Country
January 28th 2021In a progress update on COVID-19 vaccine administration and testing in Walgreens pharmacies, speakers discussed the rollout and implementation of the COVID-19 vaccination process in LTC facilities.
Read More
Research Shows Women Still Face Disparities in Global Burden of Stroke
January 27th 2021Two of the studies specifically address the concerns about the lack of women in stroke clinical trials, causing a dearth in information to ensure appropriate stroke treatment for women, which has been an issue for scientists.
Read More
Lack of Sleep, Stress Can Cause Symptoms Resembling Concussion
January 27th 2021Because there are multiple sources for concussion-like symptoms, student-athletes’ post-concussion care should zero in on which symptoms are specifically caused by the injury and which may be caused by other issues.
Read More
SCOTUS Ruling May Help Independent Community Pharmacies Rebuild
January 27th 2021Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on how the recent SCOTUS ruling on Rutledge v. PCMA may help independent community pharmacies rebuild what may have been lost due to low reimbursement rates.
Watch